Vision Scs F2 - Net Worth and Insider Trading
Vision Scs F2 Net Worth
The estimated net worth of Vision Scs F2 is at least $104 Million dollars as of 2024-05-18. Vision Scs F2 is the 10% Owner of Cullinan Therapeutics Inc and owns about 4,476,350 shares of Cullinan Therapeutics Inc (CGEM) stock worth over $104 Million. Details can be seen in Vision Scs F2's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Vision Scs F2 has not made any transactions after 2022-08-04 and currently still holds the listed stock(s).
Transaction Summary of Vision Scs F2
Vision Scs F2 Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vision Scs F2 owns 1 companies in total, including Cullinan Therapeutics Inc (CGEM) .
Click here to see the complete history of Vision Scs F2’s form 4 insider trades.
Insider Ownership Summary of Vision Scs F2
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CGEM | Cullinan Therapeutics Inc | 2022-08-04 | 10 percent owner |
Vision Scs F2 Latest Holdings Summary
Vision Scs F2 currently owns a total of 1 stock. Vision Scs F2 owns 4,476,350 shares of Cullinan Therapeutics Inc (CGEM) as of August 4, 2022, with a value of $104 Million.
Latest Holdings of Vision Scs F2
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics Inc | 2022-08-04 | 4,476,350 | 23.17 | 103,717,030 |
Holding Weightings of Vision Scs F2
Vision Scs F2 Form 4 Trading Tracker
According to the SEC Form 4 filings, Vision Scs F2 has made a total of 2 transactions in Cullinan Therapeutics Inc (CGEM) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Cullinan Therapeutics Inc is the sale of 49,910 shares on August 4, 2022, which brought Vision Scs F2 around $711,717.
Insider Trading History of Vision Scs F2
- 1
Vision Scs F2 Trading Performance
Vision Scs F2 Ownership Network
Vision Scs F2 Owned Company Details
What does Cullinan Therapeutics Inc do?
Who are the key executives at Cullinan Therapeutics Inc?
Vision Scs F2 is the 10 percent owner of Cullinan Therapeutics Inc. Other key executives at Cullinan Therapeutics Inc include See Remarks Jennifer Michaelson , Acting Chief Business Officer Savill Corrine , and director & President and CEO Nadim Ahmed .
Cullinan Therapeutics Inc (CGEM) Insider Trades Summary
Over the past 18 months, Vision Scs F2 made no insider transaction in Cullinan Therapeutics Inc (CGEM). Other recent insider transactions involving Cullinan Therapeutics Inc (CGEM) include a net sale of 83,555 shares made by Jennifer Michaelson , a net sale of 6,823 shares made by Jeffrey Trigilio , and a net sale of 3,809 shares made by Jeffrey Alan Jones .
In summary, during the past 3 months, insiders sold 63,606 shares of Cullinan Therapeutics Inc (CGEM) in total and bought 0 shares, with a net sale of 63,606 shares. During the past 18 months, 224,214 shares of Cullinan Therapeutics Inc (CGEM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 224,214 shares.
Cullinan Therapeutics Inc (CGEM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cullinan Therapeutics Inc Insider Transactions
Vision Scs F2 Mailing Address
Above is the net worth, insider trading, and ownership report for Vision Scs F2. You might contact Vision Scs F2 via mailing address: 74 Grand Rue, Luxemburg N4 L-1660.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
